NSEDCP
MRNA icon

NJ State Employees Deferred Compensation Plan’s Moderna MRNA Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,000
Closed -$244K – 554
2019
Q1 		$244K Sell
12,000
-8,000
-40% -$148K 0.04% 482
2018
Q4 		$305K Buy
+20,000
New +$329K 0.06% 370

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's MRNA Position: Q2 2019 in Review

NJ State Employees Deferred Compensation Plan sold out of Moderna (MRNA) in Q2 2019, closing a stake of 12,000 shares — an estimated $244K sold.

NJ State Employees Deferred Compensation Plan first reported a position in MRNA in Q4 2018 and held it in 2 quarters. The position peaked at $305K in Q4 2018. 138 funds tracked by Wall St. Rank hold MRNA as of Q2 2019.

  • NJ State Employees Deferred Compensation Plan reported no remaining Moderna position as of Q2 2019 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 12,000 Moderna shares in Q2 2019, an estimated $244K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Moderna in Q4 2018 and held it in 2 quarters.
  • NJ State Employees Deferred Compensation Plan's Moderna position peaked at $305K in Q4 2018.
  • 138 funds tracked by Wall St. Rank held Moderna as of Q2 2019.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2019, filed 24 Jul 2019.